Isolated hypoaldosteronism due to novel compound heterozygous mutations of the CYP11B2 gene and PHA type 1 due to a novel heterozygous mutation of NR3C2 gene each occurred in one patient. This evidence concerns the gene NR3C2 and pseudohypoaldosteronism type 1.